Henri Xhaard, Ph.D.
Computational Drug Discovery Group
Group Leader
Henri Xhaard received his Ph.D. in Biochemistry in 2006 (Åbo Akademi University, Finland). He obtained international research experience as a post-doctoral fellow at the Åbo Akademi University, Department of Biochemistry (2006-2007); and at the University Paris VI, Bioinformatics Institute (ABI) (2007). Since 2008, he has served as group leader in the CDR where he leads the Computational Drug Discovery Group. He has authored more than 10 research articles. His main interests are computational drug discovery, molecular modeling, sequence-structure-function relationships in proteins, and membrane proteins (especially G protein-coupled receptors and transporters).
Dr. Xhaard actively participates in the Drug Discovery and Chemical Biology (DDCB) consortium within Biocenter Finland (BF), a national infrastructure for drug discovery and chemical biology research in Finland. As a member of BF, Dr. Xhaard provides contract services and expertise in virtual screening, molecular modeling, chemoinformatics, and in silico ADMET. For more information or to inquire about contract services in these areas, please contact CDR.